Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center
- PMID: 33671152
- PMCID: PMC7922863
- DOI: 10.3390/cancers13040832
Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center
Abstract
Background: The impact of demographic change on the age at diagnosis in German head and neck cancer (HNC) patients is unclear. Here we present an evaluation of aging trends in HNC at a tertiary referral center.
Methods: Retrospective cohort study on aging trends at the initial diagnosis of newly diagnosed patients with HNC between 2004 and 2018 at the head and neck cancer center Ulm in relation to demographic data of the catchment area.
Results: The study population consisted of 2450 individuals diagnosed with HNC with a mean age of 62.84 (±11.67) years. We observed a significant increase in annual incidence rates and mean age over time. Mean age among HNC patients increased significantly more than among the population in the catchment area. Whereas the incidence rate of patients <50 years did not change, the incidence of HNC patients aged ≥70 years increased the most. The mean patient age in the main tumor sites increased significantly. Surprisingly, HPV-positive patients were not younger than HPV-negative patients, but showed a non-significant trend towards a higher mean age (63.0 vs. 60.7 years).
Conclusions: Increasing incidence rates in older patients pose a challenge for health care systems. A nationwide study is needed to assess the dynamics and impact of aging on the incidence of HNC.
Keywords: HPV; aging; demographics; epidemiology; head and neck cancer.
Conflict of interest statement
Simon Laban: Advisory Boards: Merck Sharp & Dohme (M.S.D.), Bristol Myers Squibb (B.M.S.), Astra Zeneca (A.Z.). Honoraria: M.S.D., B.M.S., A.Z., Merck Serono. Johannes Döscher: Advisory Boards: Merck Serono. M.S.D. Honoraria: Merck Serono. Patrick Schuler: Advisory Boards: B.M.S., M.S.D. Thomas K. Hoffmann: Advisory Boards: M.S.D., B.M.S. Honoraria: M.S.D., B.M.S., Merck Serono. All other authors declared no conflict of interests.
Figures





Similar articles
-
Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.J Oral Maxillofac Surg. 2017 Dec;75(12):2562-2572. doi: 10.1016/j.joms.2017.05.008. Epub 2017 May 22. J Oral Maxillofac Surg. 2017. PMID: 28618252 Free PMC article.
-
Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.Cancer. 2019 Jan 15;125(2):249-260. doi: 10.1002/cncr.31800. Epub 2018 Nov 16. Cancer. 2019. PMID: 30444527
-
Head and neck cancer in HIV patients and their parents: a Danish cohort study.Clin Epidemiol. 2011;3:217-27. doi: 10.2147/CLEP.S19875. Epub 2011 Jul 21. Clin Epidemiol. 2011. PMID: 21857789 Free PMC article.
-
Epidemiology of head and neck cancer.Surg Oncol Clin N Am. 2015 Jul;24(3):379-96. doi: 10.1016/j.soc.2015.03.001. Epub 2015 Apr 9. Surg Oncol Clin N Am. 2015. PMID: 25979389 Review.
-
Communicating about HPV in the context of head and neck cancer: A systematic review of quantitative studies.Patient Educ Couns. 2020 Mar;103(3):462-472. doi: 10.1016/j.pec.2019.09.017. Epub 2019 Sep 17. Patient Educ Couns. 2020. PMID: 31558324
Cited by
-
Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients.Strahlenther Onkol. 2022 Nov;198(11):1008-1015. doi: 10.1007/s00066-022-01975-6. Epub 2022 Jul 14. Strahlenther Onkol. 2022. PMID: 35833963 Free PMC article.
-
The Association between Telomere Length and Head and Neck Cancer Risk: A Systematic Review and Meta-Analysis.Int J Mol Sci. 2024 Aug 19;25(16):9000. doi: 10.3390/ijms25169000. Int J Mol Sci. 2024. PMID: 39201686 Free PMC article.
-
[HPV-related oropharyngeal squamous cell carcinoma-Incidence steadily rising].HNO. 2021 Jul;69(7):599-608. doi: 10.1007/s00106-021-01087-0. Epub 2021 Jun 18. HNO. 2021. PMID: 34143237 German.
-
Influence of travel burden on tumor classification and survival of head and neck cancer patients.Eur Arch Otorhinolaryngol. 2021 Nov;278(11):4535-4543. doi: 10.1007/s00405-021-06816-3. Epub 2021 Apr 20. Eur Arch Otorhinolaryngol. 2021. PMID: 33877433
-
Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern Germany.Cancer Med. 2023 Dec;12(23):21426-21435. doi: 10.1002/cam4.6690. Epub 2023 Dec 1. Cancer Med. 2023. PMID: 38037808 Free PMC article.
References
-
- Pison G. The population of the world. Popul. Sociétés. 2019;503:1–8.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources